Stryker is a global medical technology company founded in 1941 by Dr. Homer Stryker. It operates across three principal business segments - MedSurg, Neurotechnology, and Orthopaedics - and its product portfolio spans acute care, endoscopy, joint replacement, neurovascular, sports medicine, surgical technologies, and healthcare communications. The company operates in 75 countries and reported $22.6 billion in global sales in 2024.
The scale of Stryker's reach is considerable: its products and services touch more than 150 million patients annually. The company holds 14,200 patents and invested $1.5 billion in research and development in 2024, reflecting the central role that engineering and product innovation play in its operations.
Stryker's workforce spans a wide range of disciplines, from biomedical and mechanical engineering to clinical affairs, regulatory, sales, and software development. The breadth of its product lines - covering everything from minimally invasive surgical tools to neurovascular devices and hospital communications systems - means that technical and commercial roles exist across a diverse set of healthcare domains.